RMTI Rockwell Medical Inc
Price (delayed)
$1.19
Market cap
$40.53M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.03
Enterprise value
$37.47M
Rockwell Medical is a biopharmaceutical company dedicated to transforming anemia management in a wide variety of therapeutic areas and across the globe, improving the lives of very sick patients. The
Highlights
The gross profit has soared by 101% YoY and by 4.6% QoQ
The net income has soared by 94% YoY and by 61% QoQ
RMTI's quick ratio has soared by 132% YoY but it is down by 20% QoQ
The company's debt fell by 11% QoQ but it rose by 6% YoY
Key stats
What are the main financial stats of RMTI
Market
Valuations
Earnings
Shares outstanding
34.06M
Market cap
$40.53M
Enterprise value
$37.47M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.18
Price to sales (P/S)
0.36
EV/EBIT
48.41
EV/EBITDA
7.63
EV/Sales
0.37
Revenue
$101.49M
Gross profit
$17.48M
Operating income
$608,000
Net income
-$480,000
EBIT
$774,000
EBITDA
$4.91M
Free cash flow
$3.19M
Per share
Balance sheet
Liquidity
EPS
-$0.03
EPS diluted
-$0.03
Free cash flow per share
$0.1
Book value per share
$1.01
Revenue per share
$3.27
TBVPS
$1.55
Total assets
$59.21M
Total liabilities
$26.62M
Debt
$12.6M
Equity
$32.59M
Working capital
$22.94M
Debt to equity
0.39
Current ratio
2.63
Quick ratio
1.53
Net debt/EBITDA
-0.62
Margins
Efficiency
Dividend
EBITDA margin
4.8%
Gross margin
17.2%
Net margin
-0.5%
Operating margin
0.6%
Return on assets
-0.9%
Return on equity
-1.8%
Return on invested capital
2.5%
Return on capital employed
1.7%
Return on sales
0.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
RMTI stock price
How has the Rockwell Medical stock price performed over time
Intraday
3.48%
1 week
15.53%
1 month
-5.56%
1 year
-20.13%
YTD
-41.67%
QTD
5.31%
Financial performance
How have Rockwell Medical's revenue and profit performed over time
Revenue
$101.49M
Gross profit
$17.48M
Operating income
$608,000
Net income
-$480,000
Gross margin
17.2%
Net margin
-0.5%
Rockwell Medical's operating income has surged by 109% YoY and by 4.8% QoQ
The company's operating margin has surged by 108% YoY
The gross profit has soared by 101% YoY and by 4.6% QoQ
The company's net margin has surged by 95% YoY and by 58% QoQ
Growth
What is Rockwell Medical's growth rate over time
Valuation
What is Rockwell Medical stock price valuation
P/E
N/A
P/B
1.18
P/S
0.36
EV/EBIT
48.41
EV/EBITDA
7.63
EV/Sales
0.37
The EPS has soared by 92% YoY and by 40% from the previous quarter
RMTI's price to book (P/B) is 70% lower than its 5-year quarterly average of 3.9 and 56% lower than its last 4 quarters average of 2.7
RMTI's equity has surged by 53% year-on-year and by 12% since the previous quarter
RMTI's price to sales (P/S) is 60% lower than its 5-year quarterly average of 0.9 and 55% lower than its last 4 quarters average of 0.8
Rockwell Medical's revenue has increased by 21% YoY and by 2.6% from the previous quarter
Efficiency
How efficient is Rockwell Medical business performance
The return on invested capital has surged by 111% year-on-year but it has declined by 11% since the previous quarter
The ROS has soared by 111% YoY
RMTI's return on equity has surged by 97% year-on-year and by 65% since the previous quarter
Rockwell Medical's return on assets has surged by 95% YoY and by 61% QoQ
Dividends
What is RMTI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for RMTI.
Financial health
How did Rockwell Medical financials performed over time
Rockwell Medical's total assets is 122% more than its total liabilities
RMTI's quick ratio has soared by 132% YoY but it is down by 20% QoQ
RMTI's current ratio has soared by 52% YoY and by 9% QoQ
The company's debt is 61% lower than its equity
RMTI's equity has surged by 53% year-on-year and by 12% since the previous quarter
The debt to equity has contracted by 30% YoY and by 20% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.